Related Experiment Video
Updated: Jun 13, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
The approach to triglyceride levels in patients with coronary heart disease
1Department of Internal Medicine "C", Beilinson Hospital, Rabin medical center, Petah Tikva, Israel.
Insights
Most cardiovascular disease (CVD) patients have controlled triglyceride (TG) levels. However, diabetic patients with CVD require more attention and specific treatment strategies to manage TG levels effectively.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Residual cardiovascular risk persists despite aggressive low-density lipoprotein cholesterol (LDL-C) lowering, partly due to elevated triglyceride (TG) levels.
- Cardiovascular heart disease (CHD) patients in Israel frequently do not achieve recommended LDL-C targets, even post-hospitalization.
- Similar trends are observed for triglyceride levels in this patient population.
Purpose of the Study:
- To investigate triglyceride levels in patients with cardiovascular heart disease (CHD).
- To identify specific therapeutic regimens required for managing elevated TG levels in CHD patients.
- To evaluate factors influencing TG levels, particularly very high levels.
Main Methods:
- Retrospective cohort study sub-analysis of 10,540 CHD patients admitted for anginal syndrome (2020-2022).
- Evaluation of demographic, clinical characteristics, TG levels, and lipid-lowering treatments (pre-admission, during hospitalization, and post-discharge).
- Analysis of factors affecting TG levels, with a focus on severe hypertriglyceridemia (≥ 500 mg/dL).
Main Results:
- Two-thirds of patients had TG levels < 150 mg/dL; 4-6% exhibited severe hypertriglyceridemia.
- Among patients with TG ≥ 150 mg/dL, two-thirds had HbA1c > 6.4%, indicating uncontrolled diabetes.
- Severe hypertriglyceridemia was associated with higher rates of uncontrolled diabetes mellitus; statin use was common, while fibrate use was low but higher in severe cases. Hospitalization showed no significant short-term treatment or TG level impact.
Conclusions:
- The majority of cardiovascular heart disease (CHD) patients maintain controlled triglyceride (TG) levels.
- Diabetic patients with CHD warrant increased clinical attention for TG management.
- Enhanced patient education and stricter therapeutic policies are necessary for optimal TG control in CHD patients.
Background:
Clinical trials demonstrate residual risk despite aggressive LDL-C lowering, partialy realated to high TG levels. CHD patients in Israel do not reach the recommended LDL-C target levels, even after hospitalization. Our impression is that it is the same regarding TG levels.
Objectives:
Exploring the TG levels among CHD patients and adressing specific therapeutic regimens needed.
Design And Methods:
A sub-analysis of a retrospective cohort study of CHD patients who were admitted to internal medicine wards because of anginal syndrome during 2020-2022. The data was evaluated for demographic and clinical characteristics, TG levels and lipid lowering treatment at admission, 6 months previously, 3 months and 6-9 months after discharge. The factors that affect TG levels, with attention given to very high levels, were also evaluated.
Results:
The cohort included 10,540 patients. Two-thirds had TG levels < 150 mg/dL. Among the subjects with levels ≥ 150 mg/dL, 4-6 % had severe hypertriglyceridemia (≥ 500 mg/dl). In two-thirds of the patients with TG levels ≥ 150 mg/dL, the HbA1c levels were > 6.4 %. Patient with severe hypertriglyceridemia had higher rates of uncontrolled diabetes mellitus. The majority of subjects received statin treatment, regardless of their TG levels. The use of fibrates was very low, but was significantly higher among patients with severe hypertriglyceridemia. Hospitalization did not have a clinically-significant effect on short-term treatment nor on TG levels.
Conclusions:
Most CHD patients have controlled TG levels. However, additional attention should be given to the diabetic ones. Further education and strict policy are needed.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

